Genome-wide association studies of LRRK2 modifiers of Parkinson’s disease
Dongbing Lai, Babak Alipanahi, Pierre Fontanillas, Tae-Hwi Schwantes-An, Jan Aasly, Roy N. Alcalay, Gary W. Beecham, Daniela Berg, Susan Bressman, Alexis Brice, Kathrin Brockman, Lorraine Clark, Mark Cookson, Sayantan Das, Vivianna Van Deerlin, Matthew Farrer, Joanne Trinh, Thomas Gasser, Stefano Goldwurm, Emil Gustavsson, Christine Klein, Anthony E. Lang, J. William Langston, Jeanne Latourelle, Timothy Lynch, Karen Marder, Connie Marras, Eden R. Martin, Cory Y. McLean, Helen Mejia-Santana, Eric Molho, Richard H. Myers, Karen Nuytemans, Laurie Ozelius, Haydeh Payami, Deborah Raymond, Ekaterina Rogaeva, Michael P. Rogers, Owen A. Ross, Ali Samii, Rachel Saunders-Pullman, Birgitt Schüle, Claudia Schulte, William K. Scott, Caroline Tanner, Eduardo Tolosa, James E. Tomkins, Dolores Vilas, John Q. Trojanowski, The 23andMe Research Team, Ryan Uitti, Jeffery M. Vance, Naomi P. Visanji, Zbigniew K. Wszolek, Cyrus P. Zabetian, Anat Mirelman, Nir Giladi, Avi Orr Urtreger, Paul Cannon, Brian Fiske, Tatiana Foroud
medRxiv 2020.12.14.20224378; doi: https://doi.org/10.1101/2020.12.14.20224378